Viewing data from:

DESIPRAMINE HYDROCHLORIDE

ANDA

DESIPRAMINE HYDROCHLORIDE | A074430 | ACTAVIS TOTOWA LLC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: NORPRAMIN(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.6662

per ea

Lowest NADAC/Unit

$0.1613

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
45963034650DESIPRAMINE 150 MG TABLET	$0.6662	EA	Generic	—	2026-06-17
45963034102DESIPRAMINE 10 MG TABLET	$0.1613	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain1 active DMF6 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

LUNDBECK PHARMACEUTICALS ITALY SPADESIPRAMINE HYDROCHLORIDE

DMF 33741978

FARCHEMIA SRLInactiveDESIPRAMINE HYDROCHLORIDE USP

DMF 53671984

IRISH FINE CHEMICALS LTDInactiveDESIPRAMINE HYDROCHLORIDE

DMF 66431986

ACF CHEMIEFARMA NVInactiveDESIPRAMINE HYDROCHLORIDE

DMF 66631986

ARCHIMICA SPAInactiveDESIPRAMINE HYDROCHLORIDE USP

DMF 72161987

FABBRICA ITALIANA SINTETICI SPAInactiveDESIPRAMINE HYDROCHLORIDE

DMF 74011988

PCASInactiveDESIPRAMINE HYDROCHLORIDE

DMF 104611993

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 10MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Feb 9, 1996

No patent or exclusivity listings for this strength.

#002 — 150MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Feb 9, 1996